4.7 Article

Isothermal DNA amplification coupled to Aunanoprobes for detection of mutations associated to Rifampicin resistance in Mycobacterium tuberculosis

期刊

JOURNAL OF NANOBIOTECHNOLOGY
卷 11, 期 -, 页码 -

出版社

BIOMED CENTRAL LTD
DOI: 10.1186/1477-3155-11-38

关键词

MDRTB; Nanodiagnostics; LAMP; PCR; Gold nanoparticles; Tuberculosis; DNA isothermal amplification; Rifampicin

资金

  1. Fundacao para a Ciencia e a Tecnologia (FCT-MCTES)
  2. CIGMH [PEst-OE/SAU/UI0009/2011]
  3. [PTDC/BBB-NAN/1812/2012]
  4. [PTDC/CTM-NAN/109877/2009]
  5. [SFRH/BD/78970/2011]
  6. Fundação para a Ciência e a Tecnologia [SFRH/BD/78970/2011] Funding Source: FCT

向作者/读者索取更多资源

Background: Tuberculosis accounted for 8.7 million new cases in 2011 and continues to be one of the leading human infectious diseases. Burdensome is the increasing rate of multi-drug resistant tuberculosis (MDRTB) and the difficulties created for treatment and public health control programs, especially in developing countries. Resistance to rifampicin (RIF), a first line antibiotic, is commonly associated with point mutations within the rpoB gene of Mycobacterium tuberculosis (Mtb) whose detection is considered the best early molecular predictor for MDRTB. Gold nanoparticles functionalized with thiol-modified oligonucleotides (Au-nanoprobes) have shown the potential to provide a rapid and sensitive detection method for Mtb and single base alterations associated with antibiotic resistance, namely in rpoB gene associated to RIF resistance. Results: We developed a strategy based on the isothermal amplification of sample DNA (LAMP) coupled to specific Au-nanoprobes capable of identifying members of the Mtb complex (MTBC) and discriminating specific mutations within the rpoB gene. Integration of LAMP and Au-nanoprobe assay allowed to detect MTBC member and identify mutations linked to RIF resistance. A total of 12 biological samples were tested and a 100% specificity and sensitivity was attained. Conclusions: There is an increasing demand for simple, fast and cheap methods for the molecular identification of Mtb and for the detection of molecular tags associated to drug resistance suitable for use at point-of-need. Here we describe such a method, that as the potential to get molecular diagnostic of tuberculosis to remote environments.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Pharmacology & Pharmacy

Quercetin Liposomal Nanoformulation for Ischemia and Reperfusion Injury Treatment

Margarida Ferreira-Silva, Catarina Faria-Silva, Manuela C. Carvalheiro, Sandra Simoes, H. Susana Marinho, Paulo Marcelino, Maria Celeste Campos, Josbert M. Metselaar, Eduarda Fernandes, Pedro V. Baptista, Alexandra R. Fernandes, Maria Luisa Corvo

Summary: A stable quercetin liposomal formulation was developed and characterized in this study. The anti-inflammatory potential of liposomal quercetin was evaluated in vitro and in vivo, demonstrating its effectiveness in treating hepatic IRI.

PHARMACEUTICS (2022)

Editorial Material Respiratory System

Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents: implications for diagnosis and treatment

Sophia B. Georghiou, Timothy C. Rodwell, Alexei Korobitsyn, Said H. Abbadi, Kanchan Ajbani, Jan-Willem Alffenaar, David Alland, Nataly Alvarez, Sonke Andres, Elisa Ardizzoni, Alexandra Aubry, Rossella Baldan, Marie Ballif, Ivan Barilar, Erik C. Bottger, Soumitesh Chakravorty, Pauline M. Claxton, Daniela M. Cirillo, Inaki Comas, Chris Coulter, Claudia M. Denkinger, Brigitta Derendinger, Edward P. Desmond, Jurriaan E. M. de Steenwinkel, Keertan Dheda, Andreas H. Diacon, David L. Dolinger, Kelly E. Dooley, Matthias Egger, Maha R. Farhat, Lanfranco Fattorini, Iris Finci, Laure Fournier Le Ray, Victoria Furio, Ramona Groenheit, Tawanda Gumbo, Scott K. Heysell, Doris Hillemann, Harald Hoffmann, Po-Ren Hsueh, Yi Hu, Hairong Huang, Alamdar Hussain, Farzana Ismail, Kiyohiko Izumi, Tomasz Jagielski, John L. Johnson, Priti Kambli, Kone Kaniga, G. H. R. Eranga Karunaratne, Meenu Kaushal Sharma, Peter M. Keller, Ellis C. Kelly, Margarita Kholina, Mikashmi Kohli, Katharina Kranzer, Ian F. Laurenson, Jason Limberis, S-Y Grace Lin, Yongge Liu, Alexandre Lopez-Gavin, Anna Lyander, Diana Machado, Elena Martinez, Faisal Masood, Satoshi Mitarai, Nomonde R. Mvelase, Stefan Niemann, Vladyslav Nikolayevskyy, Florian P. Maurer, Matthias Merker, Paolo Miotto, Shaheed Omar, Ralf Otto-Knapp, Moises Palaci, Juan Jose Palacios Gutierrez, Sharon J. Peacock, Charles A. Peloquin, Jennifer Perera, Catherine Pierre-Audigier, Suporn Pholwat, James E. Posey, Therdsak Prammananan, Leen Rigouts, Jaime Robledo, Neesha Rockwood, Camilla Rodrigues, Max Salfinger, Marcos C. Schechter, Marva Seifert, Sarah Sengstake, Thomas Shinnick, Natalia Shubladze, Vitali Sintchenko, Frederick Sirgel, Sulochana Somasundaram, Timothy R. Sterling, Andrea Spitaleri, Elizabeth Streicher, Philip Supply, Erik Svensson, Elisa Tagliani, Sabira Tahseen, Akiko Takaki, Grant Theron, Gabriela Torrea, Armand Van Deun, Annelies Van Rie, Dick van Soolingen, Roger Vargas, Amour Venter, Nicolas Veziris, Cristina Villellas, Miguel Viveiros, Robin Warren, Shu'an Wen, Jim Werngren, Robert J. Wilkinson, Caie Yang, Tingting Zhang, Danila Zimenkov, Nazir Ismail, Thomas Schon, Claudio U. Koser, Soudeh Ehsani, Jakko van Ingen, F. Ferda Yilmaz

EUROPEAN RESPIRATORY JOURNAL (2022)

Article Biochemistry & Molecular Biology

Molecular Beacon for Detection miRNA-21 as a Biomarker of Lung Cancer

Daniela Alexandre, Bernardo Teixeira, Andre Rico, Salete Valente, Ana Craveiro, Pedro Baptista, Carla Cruz

Summary: Lung cancer is the leading cause of cancer-related death worldwide. Non-small cell lung cancer diagnosis and treatment have advanced, but more sensitive and specific screening methods are needed. New molecular biomarkers, particularly miRNA, are emerging as potential non-invasive diagnostic agents. We developed a molecular beacon-based miRNA detection strategy for non-small cell lung cancer.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Nanoscience & Nanotechnology

Engineering gold nanoparticles for molecular diagnostics and biosensing

Beatriz B. Oliveira, Daniela Ferreira, Alexandra R. Fernandes, Pedro Viana Baptista

Summary: Advances in nanotechnology and medical science have led to the development and application of nanomaterials and nanoparticles in biomedicine. Gold nanoparticles have attracted significant interest due to their unique properties, and they hold great value for use in biodetection and diagnostics.

WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2023)

Article Infectious Diseases

Virulence Potential of Biofilm-Producing Staphylococcus pseudintermedius, Staphylococcus aureus and Staphylococcus coagulans Causing Skin Infections in Companion Animals

Mariana Andrade, Ketlyn Oliveira, Catarina Morais, Patricia Abrantes, Constanca Pomba, Adriana E. Rosato, Isabel Couto, Sofia Santos Costa

Summary: This study reveals the frequent biofilm production by antimicrobial-resistant coagulase-positive staphylococci in companion animals, which is associated with a higher virulence potential and persistent or recurrent infections.

ANTIBIOTICS-BASEL (2022)

Article Biochemistry & Molecular Biology

Occurrence and Variability of the Efflux Pump Gene norA across the Staphylococcus Genus

Carolina Ferreira, Patricia Abrantes, Sofia Santos Costa, Miguel Viveiros, Isabel Couto

Summary: This study identified the variability of norA within Staphylococcus aureus and its distribution among other staphylococci. It also demonstrated the applicability of a PCR-based algorithm to detect and differentiate norA alleles, and found the association of norA alleles with specific S. aureus clonal lineages.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Biochemical Research Methods

Combining the amplification refractory mutation system and high-resolution melting analysis for KRAS mutation detection in clinical samples

Beatriz B. Oliveira, Beatriz Costa, Barbara Morao, Sandra Faias, Bruno Veigas, Lucilia Pebre Pereira, Cristina Albuquerque, Rui Maio, Marilia Cravo, Alexandra R. Fernandes, Pedro Viana Baptista

Summary: The success of personalized medicine relies on biomarker discovery for identifying patients who will benefit from specific targeted drugs. Liquid biopsies, particularly the analysis of circulating tumor DNA, are emerging as a useful tool for diagnosis, prognosis, and biomarker discovery. In this study, an ARMS-HRMA method was developed for detecting KRAS mutations, showing simplicity, shorter time to result, high sensitivity, and specificity compared to traditional sequencing and digital PCR methods. The proposed ARMS-HRMA method has the potential to improve liquid biopsy-based diagnosis and prognosis schemes.

ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2023)

Article Infectious Diseases

Towards clinical breakpoints for non-tuberculous mycobacteria-Determination of epidemiological cut off values for the Mycobacterium avium complex and Mycobacterium abscessus using broth microdilution

Gabrielle Froberg, Florian P. Maurer, Erja Chryssanthou, Louise Fernstrom, Hanaa Benmansour, Samira Boarbi, Anne Torunn Mengshoel, Peter Michael Keller, Miguel Viveiros, Diana Machado, Margaret M. Fitzgibbon, Simone Mok, Jim Werngren, Daniela Maria Cirillo, Fernando Alcaide, Hanne-Leena Hyyrylainen, Alexandra Aubry, Sonke Andres, Darshaalini Nadarajan, Erik Svensson, John Turnidge, Christian G. Giske, Gunnar Kahlmeter, Emmanuelle Cambau, Jakko van Ingen, Thomas Schon

Summary: The study evaluated the minimum inhibitory concentration (MIC) distributions of non-tuberculous mycobacteria (NTM) to establish antimicrobial susceptibility testing (AST) breakpoints. MIC distributions for drugs against Mycobacterium avium complex (MAC) and Mycobacterium abscessus (MAB) were collected from 12 laboratories. Epidemiological cut-off values (ECOFFs) and tentative ECOFFs (TECOFFs) were determined, highlighting the need for further method refinement in establishing clinical breakpoints for NTM.

CLINICAL MICROBIOLOGY AND INFECTION (2023)

Article Biochemistry & Molecular Biology

Cell Uptake of Steroid-BODIPY Conjugates and Their Internalization Mechanisms: Cancer Theranostic Dyes

Ana F. Amendoeira, Andre Luz, Ruben Valente, Catarina Roma-Rodrigues, Hasrat Ali, Johan E. van Lier, Fernanda Marques, Pedro V. Baptista, Alexandra R. Fernandes

Summary: This study evaluated the cell uptake of Estradiol-BODIPY, 19-nortestosterone-BODIPY, and testosterone-BODIPY in breast cancer and prostate cancer cells, as well as in normal dermal fibroblasts. The results showed that the highest internalization occurred in cells expressing specific receptors for the compounds. Blocking experiments also revealed differences in non-specific cell uptake between cancer and normal cells, possibly due to differences in lipophilicity. The internalization process was energy-dependent and mediated by clathrin- and caveolae-endocytosis. Co-culture studies demonstrated that the compounds exhibited selectivity towards cancer cells. Furthermore, the compounds showed non-toxicity towards cancer and/or normal cells, and visible light irradiation induced cell death, indicating their potential use as PDT agents.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Chemistry, Medicinal

In Vitro and In Vivo Biological Activities of Dipicolinate Oxovanadium(IV) Complexes

Katarzyna Choroba, Beatriz Filipe, Anna Switlicka, Mateusz Penkala, Barbara Machura, Alina Bienko, Sandra Cordeiro, Pedro V. Baptista, Alexandra R. Fernandes

Summary: The study focused on the anticancer properties of dipicolinate-basedvanadium(IV) complexes with different diimines. These complexes showed high cytotoxic effect against HCT116-DoxR cells and induced cell death through apoptosis and autophagy pathways. They also interacted with BSA protein and did not promote tumor cell migration or angiogenesis.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Chemistry, Analytical

Hybrid Digital-Droplet Microfluidic Chip for Applications in Droplet Digital Nucleic Acid Amplification: Design, Fabrication and Characterization

Beatriz J. Coelho, Joana P. Neto, Barbara Sieira, Andre T. Moura, Elvira Fortunato, Rodrigo Martins, Pedro V. Baptista, Rui Igreja, Hugo Aguas

Summary: Microfluidic-based platforms are powerful tools for chemical and biological assays. The fusion of different microfluidic technologies has the potential to overcome limitations and enhance their strengths.

SENSORS (2023)

Article Polymer Science

Parylene C as a Multipurpose Material for Electronics and Microfluidics

Beatriz J. Coelho, Joana V. Pinto, Jorge Martins, Ana Rovisco, Pedro Barquinha, Elvira Fortunato, Pedro V. Baptista, Rodrigo Martins, Rui Igreja

Summary: Poly(p-xylylene) derivatives, also known as Parylenes, have been extensively studied for their thermal, structural, and electrical properties. This article explores the application of Parylene C in various electronic devices, including transistors, capacitors, and digital microfluidic devices. The results show that Parylene C can be used as a dielectric, substrate, and encapsulation layer in transistors, producing high performance devices with steep transfer curves, low gate leak currents, and good mobilities. The study also demonstrates the functionality of Parylene C in MIM structures and its capability to enable faster droplet motion and nucleic acid amplification reactions in DMF devices.

POLYMERS (2023)

Article Pharmacology & Pharmacy

Exploring RAB11A Pathway to Hinder Chronic Myeloid Leukemia-Induced Angiogenesis In Vivo

Catarina Roma-Rodrigues, Alexandra R. Fernandes, Pedro V. Baptista

Summary: Neoangiogenesis is associated with poor prognosis in cancer, including chronic myeloid leukemia (CML). The small GTP-binding protein Rab11a plays a crucial role in the neoangiogenic process in CML patients, by controlling exosome secretion and regulating vascular endothelial factor receptors. By downregulating Rab11a mRNA in CML cells, the angiogenic potential of exosomes can be reduced, offering a potential therapeutic approach for inhibiting tumor angiogenesis.

PHARMACEUTICS (2023)

Editorial Material Public, Environmental & Occupational Health

Antimicrobial resistance, society and environment: A glocal syndemic

Paulo Ferrinho, Miguel Viveiros, Ines Fronteira

ONE HEALTH (2023)

Review Biochemistry & Molecular Biology

Half-sandwich Ru(II) N-heterocyclic carbene complexes in anticancer drug design

Oscar A. Lenis Rojas, Sandra Cordeiro, Pedro V. Baptista, Alexandra R. Fernandes

Summary: The ruthenium arene fragment is a valuable source for designing anticancer drugs, and the co-ligand plays a crucial role in obtaining effective anticancer complexes. N-heterocyclic carbenes (NHCs), despite their versatility and ability to stabilize metal ions, have not been extensively explored. However, recent advancements have been made in the development of NHC ruthenium arene complexes as potent anticancer agents.

JOURNAL OF INORGANIC BIOCHEMISTRY (2023)

暂无数据